These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11927522)

  • 1. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.
    Sinisalo J; Mattila K; Valtonen V; Anttonen O; Juvonen J; Melin J; Vuorinen-Markkola H; Nieminen MS;
    Circulation; 2002 Apr; 105(13):1555-60. PubMed ID: 11927522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris).
    Marrugat J; García M; Elosua R; Aldasoro E; Tormo MJ; Zurriaga O; Arós F; Masiá R; Sanz G; Valle V; López De Sá E; Sala J; Segura A; Rubert C; Moreno C; Cabadés A; Molina L; López-Sendón JL; Gil M; ; ; ; ;
    Am J Cardiol; 2004 Nov; 94(9):1161-5. PubMed ID: 15518611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
    Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
    Berg HF; Maraha B; Scheffer GJ; Quarles-van Ufford M; Vandenbroucke-Grauls CM; Peeters MF; Kluytmans JA
    Clin Infect Dis; 2005 Feb; 40(3):358-65. PubMed ID: 15668857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.
    Gurfinkel E; Bozovich G; Daroca A; Beck E; Mautner B
    Lancet; 1997 Aug; 350(9075):404-7. PubMed ID: 9259655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study.
    Gurfinkel E; Bozovich G; Beck E; Testa E; Livellara B; Mautner B
    Eur Heart J; 1999 Jan; 20(2):121-7. PubMed ID: 10099908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
    Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
    Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
    Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
    Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis.
    Paju S; Pussinen PJ; Sinisalo J; Mattila K; Doğan B; Ahlberg J; Valtonen V; Nieminen MS; Asikainen S
    Atherosclerosis; 2006 Oct; 188(2):412-9. PubMed ID: 16388809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
    Stone AF; Mendall MA; Kaski JC; Edger TM; Risley P; Poloniecki J; Camm AJ; Northfield TC
    Circulation; 2002 Sep; 106(10):1219-23. PubMed ID: 12208796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
    Tonkin AM; Colquhoun D; Emberson J; Hague W; Keech A; Lane G; MacMahon S; Shaw J; Simes RJ; Thompson PL; White HD; Hunt D
    Lancet; 2000 Dec; 356(9245):1871-5. PubMed ID: 11130382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
    Antman EM; McCabe CH; Gurfinkel EP; Turpie AG; Bernink PJ; Salein D; Bayes De Luna A; Fox K; Lablanche JM; Radley D; Premmereur J; Braunwald E
    Circulation; 1999 Oct; 100(15):1593-601. PubMed ID: 10517729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Sätre H; Holmvang L; Wagner GS; Lindahl B; Wallentin L
    Eur Heart J; 1999 May; 20(9):645-52. PubMed ID: 10208784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.
    Circulation; 1998 Jun; 97(24):2386-95. PubMed ID: 9641689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of timing of cardiac catheterization to outcomes in patients with non-ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational global registry of acute coronary events.
    Montalescot G; Dabbous OH; Lim MJ; Flather MD; Mehta RH;
    Am J Cardiol; 2005 Jun; 95(12):1397-403. PubMed ID: 15950559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.